gms | German Medical Science

81. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

12.05. - 16.05.2010, Wiesbaden

Artikel

Artikel empfehlen

P16INK4A immunostaining patterns differentiate between the presence of high and low risk human papillomavirus types in head and neck dysplasias and papillomas

Meeting Abstract

Suche in Medline nach

  • corresponding author Jeroen Mooren - Maastricht University Medical Centre, Maastricht, the Netherlands
  • Elif Gültekin - University of Cologne, Germany
  • Bernd Kremer - Maastricht UMC, Maastricht, The Netherlands
  • Jens Klussmann - University of Gießen, Germany
  • Sandra Claessen - Maastricht UMC, Maastricht, The Netherlands
  • Annick Haesevoets - Maastricht UMC, Maastricht, The Netherlands
  • Hans Dienes - University of Cologne, Germany
  • Soenke Weissenborn - University of Cologne, Germany
  • Christian Huebbers - Maastricht UMC, Maastricht, The Netherlands
  • Ernst-Jan Speel - Maastricht UMC, Maastricht, The Netherlands

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 81. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Wiesbaden, 12.-16.05.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. Doc10hnod191

doi: 10.3205/10hnod191, urn:nbn:de:0183-10hnod1911

Veröffentlicht: 22. April 2010

© 2010 Mooren et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.

Gliederung

Text

Introduction: Human papillomavirus (HPV) is a risk factor for head and neck mucosa lesions, including HPV-16 in tonsillar squamous cell carcinomas (TSCC) and HPV-6/11 in laryngeal papillomas. The aim of this study was to determine whether expression of the HPV surrogate marker p16INK4A could predict the presence of high and low risk HPV types in head and neck dysplasias and papillomas.

Methods: P16INK4A immunostaining was performed on paraffin-embedded tissue sections of 8 laryngeal dysplasias (from 4 patients), 14 tonsillar dysplasias (12 patients), 27 laryngeal papillomas (14 patients) and 20 tonsillar papillomas (20 patients). Genomic DNA isolated from these tissues was examined for HPV type by PCR and enzyme-immunoassay analysis. FISH specific for HPV-types 6, 11 and 16 was performed to evaluate HPV physical status.

Results: A strong p16INK4A immunostaining was predominantly seen in tonsillar dysplasias and associated with integrated HPV-16, except for 1 case showing episomal HPV (9/11 cases). A predominantly intermediate p16INK4A expression level was associated with episomal HPV-6 or 11 in laryngeal dysplasias (3/4 cases) and papillomas (13/14). Low p16INK4A expression levels were detected in tonsillar papillomas, which were HPV-negative. Lesions harboring low-risk HPV-types more often showed a higher p16INK4A staining intensity in the nucleus than in the cytoplasm, whereas this pattern was not explicit in the lesions with high-risk HPV.

Conclusion: A strong p16INK4A overexpression predicts the presence of high-risk HPV-16 in tonsillar dysplasias. Less intense p16INK4A expression may be the result of an infection with low-risk HPV in laryngeal dysplasias and papillomas, or a HPV-unrelated mechanism in tonsillar papillomas.